Seneca Therapeutics, Inc
Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus. SVV-001 is already in Phase I/II and has a clinical safety record in humans. SVV-001 binds to the TEM8 receptor which is common in many solid tumors like breast cancer, lung cancer and neuroendocrine tumors. SVV-001 is also being considered as a viral vector for gene therapy targeting the TEM8 receptor in solid tumors.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
147
organic / mo
Sign up free to see all 6 verified contacts at Seneca Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- HT
Hung Trinh
Ö Ü · Other
EmailPhone - PH
Paul Hallenbeck
Founder, President, Chief Scientific Officer · General Business & Management
EmailPhone - JI
Janice Ingram
Corporate Secretary · General Business & Management
EmailPhone
Showing 3 of 6 verified contacts
Top roles at Seneca Therapeutics, Inc
5 distinct titles indexed · top 5 shown.
- 1corporate secretary
- 1founder, president, chief scientific officer
- 1human resources business partner
- 1professional
- 1ö ü
Sign up to unlock all 6 contacts at Seneca Therapeutics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Seneca Therapeutics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.